With 53,000 employees worldwide, Boehringer Ingelheim is a leading global pharmaceutical company that aims to develop novel treatments and technologies. Boehringer Ingelheim invites talented early-career researchers to solve pre-defined scientific questions with innovative solutions for the benefit of patients. Memb...

From understanding carnivorous plants to developing antimicrobial strategies for pen injectors, Sofia Wareham Mathiassen’s research life is characterized by high levels of curiosity and inventiveness. And in many ways, she has only just begun. Sofia Wareham Mathiassen is a biomedical engineer from the Danish ...

Earlier this year saw the establishment of a new research centre focusing on making a difference for people with metabolic disease through RNA medicine. Professor of Medical Biology and member of the DDEA Committee for Education, Louise Torp Dalgaard, will be one of the driving forces behind the new centre. The Cent...

A study found a very high seroprevalence of SARS-CoV-2 antibodies in mother-children pairs in rural north-eastern Tanzania. Line Hjort shares her insights from the study, as well as from her time doing research in Tanzania while the country’s government was downplaying the COVID-19 pandemic. During the first year ...

A proof-of-concept study by DDA-funded Visiting Professor Sam El-Osta’s team demonstrates that ductal cells derived from the human pancreas can be influenced by pharmacological stimulation to regenerate beta-like cells that functionally release insulin. – While pharmaceutical options receive warranted attent...

A Danish Diabetes Academy-funded postdoc project by researcher Rasmus Wibaek and colleagues recently published in Diabetologia gains special attention. The study used data from as far back as 1939 to examine the association between birth weight and risk of type 2 diabetes. For every kilogram added to the birth weigh...

Obesity, diabetes, cardiovascular and hormone-related diseases are closely related and growing in number of affected individuals worldwide. This is reflected in the 13 million Danish kroner research grant allocation from the Danish Diabetes and Endocrine Academy (DDEA) to 13 Danish and international early-career res...

PhD Student and Danish Diabetes Academy grantee Mark P.P. Lyngbæk shares his insights from a study recently published in Nature Metabolism. People with type 2 diabetes benefit greatly from both exercising and dietary weight loss. It may help them reduce or even discontinue their medication. And a little goes a long...

Direct patient involvement in health research can have great advantages. Ph.D. Student Caroline Bruun Abild has first-hand experience from a recent qualitative study on disordered eating in people with type 1 diabetes. People with type 1 diabetes have an increased risk of disordered eating and eating disorders. This...

Motherhood comes with a million questions: How much should my baby sleep? How often should I change their diaper? To mothers with type 1 diabetes, however, motherhood comes with the additional question of: If I breastfeed my baby, does it affect my blood glucose levels and health? DDA-funded PhDs Gitte Øskov Skajaa...

How many people live with diabetes in Denmark? What is the distribution across geography? And how many have an average blood sugar level ≤ 53 or retinopathy? For the first time, it is now possible to get a full picture of diabetes in Denmark in just one place. The Danish Diabetes Association has just launched...

Since the 19th century, lactate has been regarded as a simple waste product of cellular metabolism. In fact, it is still by many people believed to bring about that tickling feeling of burning muscles you get during exhaustive exercise. Yet, within the last two decades, the view of lactate has changed tremendou...

A study of gestational diabetes mellitus in Denmark turned into Cathrine Munk Scheuer and her team identifying significant differences in prevalence across the Danish regions that could not be explained merely by risk factors. Cathrine Munk Scheuer is a medical doctor from the University of Copenhagen. She is curren...

Danish Diabetes Academy-funded researcher Julie Abildgaard is first author of a recent cohort study investigating patients with testosterone deficiency after treatment for prostate cancer. Julie is also one of the new members of the Danish Diabetes and Endocrine Academy (DDEA) Board of Directors. Julie Abildgaard is...

Danish Diabetes Academy-funded researcher Julie Abildgaard is first author of a recent cohort study investigating patients with testosterone deficiency after treatment for prostate cancer. Julie is also one of the new members of the Danish Diabetes and Endocrine Academy (DDEA) Board of Directors. Julie Abildgaard is...